Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

Similar articles for PubMed (Select 22010039)

1.

Response of patients with refractory myasthenia gravis to rituximab: a retrospective study.

Nowak RJ, Dicapua DB, Zebardast N, Goldstein JM.

Ther Adv Neurol Disord. 2011 Sep;4(5):259-66. doi: 10.1177/1756285611411503.

2.

Rituximab in the management of refractory myasthenia gravis.

Zebardast N, Patwa HS, Novella SP, Goldstein JM.

Muscle Nerve. 2010 Mar;41(3):375-8. doi: 10.1002/mus.21521.

PMID:
19852027
3.

Long-lasting treatment effect of rituximab in MuSK myasthenia.

Díaz-Manera J, Martínez-Hernández E, Querol L, Klooster R, Rojas-García R, Suárez-Calvet X, Muñoz-Blanco JL, Mazia C, Straasheijm KR, Gallardo E, Juárez C, Verschuuren JJ, Illa I.

Neurology. 2012 Jan 17;78(3):189-93. doi: 10.1212/WNL.0b013e3182407982. Epub 2012 Jan 4.

PMID:
22218276
4.

Plasma exchange for myasthenia gravis.

Gajdos P, Chevret S, Toyka K.

Cochrane Database Syst Rev. 2002;(4):CD002275. Review.

PMID:
12519572
5.

Treatment of MuSK-Associated Myasthenia Gravis.

El-Salem K, Yassin A, Al-Hayk K, Yahya S, Al-Shorafat D, Dahbour SS.

Curr Treat Options Neurol. 2014 Apr;16(4):283. doi: 10.1007/s11940-014-0283-8.

PMID:
24504626
6.
7.

Development of generalized disease at 2 years in patients with ocular myasthenia gravis.

Kupersmith MJ, Latkany R, Homel P.

Arch Neurol. 2003 Feb;60(2):243-8.

PMID:
12580710
8.

Paraneoplastic syndromes of the neuromuscular junction: therapeutic options in myasthenia gravis, lambert-eaton myasthenic syndrome, and neuromyotonia.

van Sonderen A, Wirtz PW, Verschuuren JJ, Titulaer MJ.

Curr Treat Options Neurol. 2013 Apr;15(2):224-39. doi: 10.1007/s11940-012-0213-6.

PMID:
23263888
9.

Autoimmune mediated neuromuscular junction defects.

Farrugia ME, Vincent A.

Curr Opin Neurol. 2010 Oct;23(5):489-95. doi: 10.1097/WCO.0b013e32833cc968. Review.

PMID:
20651592
10.

Myasthenia gravis and the neuromuscular junction.

Querol L, Illa I.

Curr Opin Neurol. 2013 Oct;26(5):459-65. doi: 10.1097/WCO.0b013e328364c079. Review.

PMID:
23945282
11.

Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis.

Pevzner A, Schoser B, Peters K, Cosma NC, Karakatsani A, Schalke B, Melms A, Kröger S.

J Neurol. 2012 Mar;259(3):427-35. doi: 10.1007/s00415-011-6194-7. Epub 2011 Aug 5.

PMID:
21814823
12.

Prolonged improvement after rituximab: two cases of resistant muscle-specific receptor tyrosine kinase + myasthenia gravis.

Burusnukul P, Brennan TD, Cupler EJ.

J Clin Neuromuscul Dis. 2010 Dec;12(2):85-7. doi: 10.1097/CND.0b013e3181fcc109.

PMID:
21386776
13.

Successful treatment of refractory generalized myasthenia gravis with rituximab.

Lebrun C, Bourg V, Tieulie N, Thomas P.

Eur J Neurol. 2009 Feb;16(2):246-50. doi: 10.1111/j.1468-1331.2008.02399.x.

PMID:
19146644
14.

Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.

Plosker GL, Figgitt DP.

Drugs. 2003;63(8):803-43. Review.

PMID:
12662126
15.

Rituximab for myasthenia gravis: three case reports and review of the literature.

Stieglbauer K, Topakian R, Schäffer V, Aichner FT.

J Neurol Sci. 2009 May 15;280(1-2):120-2. doi: 10.1016/j.jns.2009.02.357. Epub 2009 Mar 9. Review.

PMID:
19272616
16.

Diagnosis and therapy of myasthenia gravis with antibodies to muscle-specific kinase.

Evoli A, Padua L.

Autoimmun Rev. 2013 Jul;12(9):931-5. doi: 10.1016/j.autrev.2013.03.004. Epub 2013 Mar 25. Review.

PMID:
23535158
17.

Update on muscle-specific tyrosine kinase antibody positive myasthenia gravis.

Guptill JT, Sanders DB.

Curr Opin Neurol. 2010 Oct;23(5):530-5. doi: 10.1097/WCO.0b013e32833c0982. Review.

PMID:
20613516
18.

Sustained response to Rituximab in anti-AChR and anti-MuSK positive Myasthenia Gravis patients.

Illa I, Diaz-Manera J, Rojas-Garcia R, Pradas J, Rey A, Blesa R, Juarez C, Gallardo E.

J Neuroimmunol. 2008 Sep 15;201-202:90-4. doi: 10.1016/j.jneuroim.2008.04.039. Epub 2008 Jul 23.

PMID:
18653247
19.

[Long-term treatment of refractory myasthenia gravis with immunoadsorption].

Wagner S, Janzen RW, Mohs C, Pohlmann S, Klingel R, Grützmacher PW.

Dtsch Med Wochenschr. 2008 Nov;133(46):2377-82. doi: 10.1055/s-0028-1100928. Epub 2008 Nov 4. German.

PMID:
18988129
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk